Analyst Conference Summaries

Biotechnology Investor Aids

Moderna
MRNA

conference date: August 5, 2021 @ 5:00 AM Pacific Time

Moderna: $30 Billion Market Capitalization is Rich July 29, 2020 @ Seeking Alpha

Moderna: mRNA Therapy Potential Worth Accumulating March 14, 2019 @ Seeking Alpha

2021
Moderna
Q4 2020
Moderna
Q1 2021
Moderna
Q2 2021
 
Feb. 25, 2021 May 6, 2021 Aug. 5, 2021  
2020
Moderna
Q4 2019
Moderna
Q1 2020
Moderna
Q2 2020
Moderna
Q3 2020
Feb. 26, 2020 May 7, 2020 Aug. 5, 2020 Oct. 29, 2020
2019
Moderna
Q4 2018
Moderna
Q1 2019
Moderna
Q2 2019
Moderna
Q3 2019
March 6, 2019 May 8, 2019 August 7, 2019 Nov. 6, 2019

Moderna (MRNA) is a clinical-stage biotechnology company specializing in RNA based therapies.

Moderna web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 CLSN
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 PLX
 REGN
 RNA
 SAGE
 SGEN
 SYRS
 TTPH
 VBLT
 VSTM
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers